Final results from a landmark study looking at the use of GSK's Mosquirix malaria vaccine alongside antimalarial drugs and other measures have shown a 90%-plus reduction in cases. The study in ...

BSI’s goal is to make QS-21 accessible to a wider range of vaccines and populations, particularly in low-income countries.

The Trump administration intends to terminate the United States’ financial support for Gavi, the organization that has helped purchase critical ...

A team at GSK has identified what could be an entirely new weapon in the fight to eradicate malaria – but it isn't a new vaccine or antimalarial compound. Working with scientists at Johns ...

Good evening and welcome to Dyadic International's Year-End 2024 Conference Call. Currently, all participants are in a listen-only mode. Following management's prepared remarks, there will be a brief ...

Testing has confirmed that an initially unidentified illness that killed more than 50 people in northwest Democratic Republic of Congo was malaria ... GSK studying if best-selling shingles vaccine ...

GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...

The difference may be luck, or it may have something to do with the world’s first malaria vaccine. The vaccine has been ...

The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...

The FDA approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new ...

The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...